The actin binding protein drebrin helps to protect against the development of seizure-like events in the entorhinal cortex.
Autorzy:
Klemz A; Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. Kreis P; Institute of Biochemistry, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany. . EickholtBJ; Institute of Biochemistry, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany. Gerevich Z; Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 21; Vol. 11 (1), pp. 8662. Date of Electronic Publication: 2021 Apr 21.
Unique properties of PTEN-L contribute to neuroprotection in response to ischemic-like stress.
Autorzy:
Jochner MCE; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany.; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany. An J; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany.; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Medical Research Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Lättig-Tünnemann G; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany.; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany. Kirchner M; Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany.; Berlin Institute of Health (BIH), Proteomics Platform, 10178 Berlin, Germany. Dagane A; Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany. Dittmar G; Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany.; Proteome and Genome Research Laboratory, Luxembourg institute of Health, 1a Rue Thomas Edison, 1224, Strassen, Luxembourg. Dirnagl U; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany.; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany.; German Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.; Charité-Universitätsmedizin Berlin, Institute of Biochemistry, Berlin, Germany. EickholtBJ; Charité-Universitätsmedizin Berlin, Institute of Biochemistry, Berlin, Germany. Harms C; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany. .; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany. .; Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 28; Vol. 9 (1), pp. 3183. Date of Electronic Publication: 2019 Feb 28.
Engineering FKBP-Based Destabilizing Domains to Build Sophisticated Protein Regulation Systems.
Autorzy:
An W; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom.; Charité - Universitätsmedizin Berlin, Cluster of Excellence NeuroCure and Institute of Biochemistry, Berlin, 10117, Germany. Jackson RE; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom. Hunter P; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom. Gögel S; Charité - Universitätsmedizin Berlin, Cluster of Excellence NeuroCure and Institute of Biochemistry, Berlin, 10117, Germany. van Diepen M; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom. Liu K; Department of Craniofacial Development, King's College London, London, SE1 1UL, United Kingdom. Meyer MP; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom. EickholtBJ; MRC Centre for Developmental Neurobiology, King's College London, London, SE1 1UL, United Kingdom.; Charité - Universitätsmedizin Berlin, Cluster of Excellence NeuroCure and Institute of Biochemistry, Berlin, 10117, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Dec 30; Vol. 10 (12), pp. e0145783. Date of Electronic Publication: 2015 Dec 30 (Print Publication: 2015).
Short Lives with Long-Lasting Effects: Filopodia Protrusions in Neuronal Branching Morphogenesis.
Autorzy:
Leondaritis G; Department of Pharmacology, Medical School, University of Ioannina, Ioannina, Greece. EickholtBJ; Institute of Biochemistry & Neuro Cure Cluster of Excellence, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2015 Sep 03; Vol. 13 (9), pp. e1002241. Date of Electronic Publication: 2015 Sep 03 (Print Publication: 2015).
Drebrin regulates neuroblast migration in the postnatal mammalian brain.
Autorzy:
Sonego M; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom. Oberoi M; Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California, United States of America. Stoddart J; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom. Gajendra S; MRC Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Hendricusdottir R; MRC Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Oozeer F; MRC Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Worth DC; MRC Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Hobbs C; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom. EickholtBJ; Cluster of Excellence NeuroCure and Institute of Biochemistry, Charité -Universitätsmedizin Berlin, Berlin, Germany. Gordon-Weeks PR; MRC Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Doherty P; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom. Lalli G; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 May 06; Vol. 10 (5), pp. e0126478. Date of Electronic Publication: 2015 May 06 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Mutations in PTRH2 cause novel infantile-onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness.
Autorzy:
Hu H; Max Planck Institute for Molecular Genetics Berlin, Germany. Matter ML; The University of Hawaii Cancer Center Honolulu, Hawaii. Issa-Jahns L; Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin Berlin, Germany ; Department of Pediatric Neurology, Charité - Universitätsmedizin Berlin Berlin, Germany. Jijiwa M; The University of Hawaii Cancer Center Honolulu, Hawaii. Kraemer N; Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin Berlin, Germany ; Department of Pediatric Neurology, Charité - Universitätsmedizin Berlin Berlin, Germany. Musante L; Max Planck Institute for Molecular Genetics Berlin, Germany. de la Vega M; The University of Hawaii Cancer Center Honolulu, Hawaii. Ninnemann O; Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin Berlin, Germany. Schindler D; Department of Human Genetics, University of Würzburg Würzburg, Germany. Damatova N; Department of Human Genetics, University of Würzburg Würzburg, Germany. Eirich K; Department of Human Genetics, University of Würzburg Würzburg, Germany. Sifringer M; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin Berlin, Germany. Schrötter S; Institute of Biochemistry and Cluster of Excellence Neurocure, Charité - Universitätsmedizin Berlin Berlin, Germany. EickholtBJ; Institute of Biochemistry and Cluster of Excellence Neurocure, Charité - Universitätsmedizin Berlin Berlin, Germany. van den Heuvel L; Nijmegen Center for Mitochondrial Disorders, Radboud University Medical Center Nijmegen, The Netherlands. Casamina C; The University of Hawaii Cancer Center Honolulu, Hawaii. Stoltenburg-Didinger G; Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin Berlin, Germany. Ropers HH; Max Planck Institute for Molecular Genetics Berlin, Germany. Wienker TF; Max Planck Institute for Molecular Genetics Berlin, Germany. Hübner C; Department of Pediatric Neurology, Charité - Universitätsmedizin Berlin Berlin, Germany. Kaindl AM; Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin Berlin, Germany ; Department of Pediatric Neurology, Charité - Universitätsmedizin Berlin Berlin, Germany.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
